Morphocell Technologies
Patrick Bedford is an accomplished regulatory affairs professional with extensive experience in the biotechnology sector. Currently serving as Vice President of Regulatory Affairs at Morphocell Technologies since April 2024, Patrick also founded and leads weCANreg Consulting Group Inc, which provides regulatory consulting services to cell and gene therapy companies. Previous roles include Vice President of Regulatory & Development at Artisan Biotechnologies, Senior Manager of Regulatory Affairs at Celgene, and Senior Manager of Clinical Translation & Regulatory Affairs at CCRM. Additionally, Patrick has held positions at Health Canada, focusing on policy development and regulatory guidance for emerging biotechnologies. Academic qualifications include an MBA from the Jack Welch Management Institute, a Master’s in Bioethics and Health Law from the University of Otago, and a Bachelor's in Health Sciences from Western University.
This person is not in any teams
This person is not in any offices
Morphocell Technologies
Morphocell Technologies Inc. is a regenerative medicine company focused on the development and commercialization of stem cell therapies and engineered tissues targeting liver failure. The Company is a spin-off of the Hepatology and Cell Therapy lab of Sainte-Justine University Hospital Center, in Montreal. Founded in April 2018 on the technology developed by Dr.Paganelli, a pediatric transplant hepatologist and stem cell scientist, Morphocell Technologies aims at bringing to market the first effective treatment for acute, chronic and acute-on-chronic liver failure.